The relationship between GAP stage and quality of life in IPF and systemic sclerosis-related ILD is diagnosis-dependent

M. Durheim (Oslo, Norway), A. Hoffman-Vold (Oslo, Norway), T. Eagan (Bergen, Norway), A. Hovden (Asker, Norway), M. Lund (Oslo, Norway), G. Bjerke (Lørenskog, Norway), T. Jonassen (Bergen, Norway), O. Johansen (Asker, Norway), T. Sjåheim (Oslo, Norway)

Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Durheim (Oslo, Norway), A. Hoffman-Vold (Oslo, Norway), T. Eagan (Bergen, Norway), A. Hovden (Asker, Norway), M. Lund (Oslo, Norway), G. Bjerke (Lørenskog, Norway), T. Jonassen (Bergen, Norway), O. Johansen (Asker, Norway), T. Sjåheim (Oslo, Norway). The relationship between GAP stage and quality of life in IPF and systemic sclerosis-related ILD is diagnosis-dependent. 3534

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A comparison of heath-related quality of life in IPF and systemic sclerosis-related ILD
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019

Is there a relationship between quality of life and exercise performance in idiopathic pulmonary fibrosis (IPF)?
Source: Eur Respir J 2007; 30: Suppl. 51, 577s
Year: 2007

The association between functional and HRQOL (K-BILD) outcome measures in IPF and other fibrotic ILDs
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018


Estimating the effectiveness of pulmonary rehabilitation for different severity of COPD, ILD and IPF
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020


Prognosis symptoms, quality of life and comorbidity relationship with cough in patients with idiopathic pulmonary fibrosis
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

The impact of treatment of chronic obstructive pulmonary disease (COPD) on functional status and quality of life of patients
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012

Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Systemic inflammation, quality of life and comorbidity in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 39s
Year: 2007

Correlation between pulmonary function test (PFT) parameters and quality of life (QoL) and dyspnea in stable chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007



The effect of multiple sclerosis on pulmonary functions and quality of life
Source: Eur Respir J 2006; 28: Suppl. 50, 285s
Year: 2006

A longitudinal study of anxiety and depression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013


Relationship between patient pulmonary function, exercise capacity and quality of life in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012

Relationship between quality of life, exercise capacity and disease severity in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life
Year: 2011


Relationship between quality of life, exercise capacity and disease severity in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011

Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020

Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes?
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Bosentan in idiopathic pulmonary fibrosis (IPF): quality of life (QOL) results of the BUILD 1 study
Source: Annual Congress 2006 - Quality of life in various respiratory diseases
Year: 2006


Relationship between severity of bronchial and systemic inflammation, and dyspnea, exercise performance and quality of life in patients with stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006

Correlation between the quality of life questionnaires and pulmonary lung functions in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 215s
Year: 2003